V. Payne

Phase II study of fulvestrant (faslodex®) in castration resistant prostate cancer

D. Trump, E. Levine, P. Escott, 2008, The Prostate.

Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (Calcitriol) in combination with dexamethasone for castration‐resistant prostate cancer

D. Trump, Candace S. Johnson, M. Wong, 2010, Cancer.